Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Blood sugar level Fasting 125mg/dl to 250mg/dl post Prandial 150mg/dl&350mg/dl 2.HbA1C 6.5 %&10%
Exclusion criteria
Exclusion criteria: 1.Patient below 18YRS to Above 70 Yrs 2.Patient with type 1 diabetes Mellitus 3.Patient With Malignant Condition And Accelerated hypertension and Systematic Disease 4.Patient With Known Complication Of DM 5.Pregnant women and Lactating mother
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| efficacy of Aamra pallav(mangnifera indica linn)in reducing prameha /Diabetes Mellitus - parameter being blood sugar leval fasting and post prandial blood sugar level And hba1c 2.Efficacy of Aamra twak (mangnifera indica linn)in reducing prameha/ Diabetes Mellitus- parameter being blood sugar level (fasting and post prandial)and hba1c 3.Efficacy Aamra pushpa (Mangnifera indica linn.)in reducing prameha/Diabetes mellitus parameter being blood sugar level (fasting and post pradinal )and hba1c 4.Comparison between Aamra pallav , Aamra twak and Aamra pushpa churna in pramehaTimepoint: FROM START AND AFTER 3 MONTH | — |
Secondary
| Measure | Time frame |
|---|---|
| Authentication and standardization-analytical study 1.Pharmacognosy -macroscopic and microscopic studies 2. Phytochemical study 3.Standardisation of drugs Literature study of aamra Comparative study of aamra different part (prayoga anga) ADR (adverse drugs rection ) if noted in patientTimepoint: 90 days;Authentication and standardization-analytical study 1.Pharmacognosy -macroscopic and microscopic studies 2. Phytochemical study 3.Standardisation of drugs Literature study of aamra Comparative study of aamra different part (prayoga anga) ADR (adverse drugs rection ) if noted in patientTimepoint: 90 days | — |
Countries
India
Contacts
Maharashtra University Of Health Science , Nashik